NBY News and Press, NovaBay Pharmaceuticals Inc. From 09/23/22

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Ladenburg Thalmann 2022 Healthcare Conf...

NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the September Life Sciences Virtual Investor Conference are now available for on-demand viewing. REGISTER NOW OR...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Virtual Life Sciences Investor Forum on Th...

NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...

Calm Cool + Corrected Eczema + Dermatitis Clinical Repair Balm to be Featured on “Girls’ Night In with Courtney & Jane” on September 13 at 9 p.m. Eastern Time NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing an...

NovaBay Pharma ( NYSE: NBY ) said on Friday it had entered into a securities purchase agreement with certain institutional investors for a private placement of 3,250 shares of a newly created Series C Non-Voting Convertible Preferred Stock at a price of $1,000 per share. T...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a Securities Purchase Agreement with certain institutional investors in connection with a private placement of 3,250 shares of a newly cre...

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2022 Earnings Conference Call August 11, 2022, 04:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Kim Sharts...

NovaBay press release ( NYSE: NBY ): Q2 GAAP EPS of -$0.04 in-line. Revenue of $3.04M (+42.7% Y/Y) misses by $0.47M . For further details see: NovaBay GAAP EPS of -$0.04 in-line, revenue of $3.04M misses by $0.47M

Product revenue increased by 43% year-over-year, fueled by a growing product portfolio in the eyecare and skincare markets Continued year-over-year growth in online Avenova ® Spray unit sales Launched seven new OTC Avenova and DERMAdoctor ® products...